Egypt EDA Medical Device Register Analysis: 3,959 Devices and Top Manufacturers
An in-depth analysis of 3,959 medical device registrations under the Egyptian Drug Authority, exploring top manufacturers, countries of origin, and timeline trends.
Executive Summary & Direct Answer
Egypt is the largest healthcare market in North Africa and one of the fastest-growing medical technology hubs in the Middle East. Over the past several years, the Egyptian Drug Authority (EDA) has undertaken a comprehensive digitization and modernization of its medical device registration system. This transition from paper-based submissions to the online MeDevice portal has significantly altered the regulatory landscape.
To provide regulatory affairs professionals, market-entry strategists, and medtech manufacturers with quantitative, database-backed insights, this analysis examines the aggregate statistics from the official Egypt EDA medical device register.
Based on a detailed extraction and analysis of the 3,959 registered medical devices in the EDA public e-service database, several key trends emerge:
- Multinational Domination in High-Risk Segments: The registry is highly concentrated, with Boston Scientific Corporation leading all registered manufacturers with 130 registrations that list it as the primary manufacturer (and close to 148 records across all Boston Scientific entities, including its Irish and Costa Rican subsidiaries).
- Growing Domestic Manufacturing Presence: Egypt's domestic manufacturers have successfully registered a significant number of products. Ameco Medical Industries leads local Egyptian manufacturers with 42 approved device registrations, followed by Pharmaplast S.A.E with 28 approvals.
- United States Leads Exporters: Among the records where the country-of-origin field is populated (note: 79.5% of records are blank in the public view), the United States leads with 125 registrations, followed by Egypt with 103, China with 93, and Italy with 56.
- Rapid Licensing Growth via MeDevice: Approved registrations peaked in 2025 with 1,007 new registrations, up from 723 in 2024, 442 in 2023, and only 106 in 2018, demonstrating the rapid digitization and clearing of backlogs under the new electronic submission platform.
This post analyzes these statistics to help manufacturers navigate Egypt's registration pathways, evaluate competitor landscapes, and optimize their Egyptian Registration Holder (ERH) strategies.
Regulatory Context: Modernizing Egypt's Device Registrations
The Egyptian Drug Authority (EDA) was established under Law No. 151 of 2019 as the sole regulatory authority responsible for pharmaceuticals, biological products, cosmetics, and medical devices. This law replaced the older Central Administration of Pharmaceutical Affairs (CAPA) and unified regulatory oversight under one body reporting directly to the Prime Minister.
To streamline the registration process and align with international standards (such as the EU MDR classification system), the EDA launched the MeDevice electronic portal (medevice.edaegypt.gov.eg). Key features of this modernized regulatory framework include:
- Online Submissions: All registration files, technical dossiers, and communications with reviewer committees are conducted digitally.
- Extended License Validity: Once approved, an EDA medical device registration certificate is typically valid for 10 years, providing long-term market access stability for manufacturers.
- Local Representative Requirements: Foreign manufacturers must appoint a local legal entity based in Egypt to act as their Egyptian Registration Holder (ERH). The ERH is legally responsible for submitting the application, maintaining the QMS, and managing post-market vigilance, as detailed in our Egypt EDA medical device registration guide.
Leading Manufacturers in the EDA Database
The EDA medical device registry exhibits high concentration, with a few large global multinationals and prominent local manufacturers holding a substantial portion of the approved registrations. The following table identifies the leading primary manufacturers (the first entity named in each record’s manufacturer field; the field frequently lists several manufacturers separated by commas) by registration count in the database:
| Primary Manufacturer | Origin | Registrations | Primary Product Portfolio |
|---|---|---|---|
| Boston Scientific Corporation | United States / Ireland | 130 | Pacemakers, cardiac catheters, coronary stents, intravascular lithotripsy systems |
| Abbott Medical | United States | 59 | Coronary and peripheral stents, structural heart devices, electrophysiology |
| Covidien (now Medtronic) | United States / Ireland | 54 | Surgical staplers, vessel-sealing devices, airway and ventilation consumables |
| Ameco Medical Industries | Egypt (Domestic) | 42 | Hemodialysis catheters, central venous catheters, interventional accessories |
| Applied Medical Resources Corporation | United States | 38 | Minimally invasive surgical access systems, trocars, wound retractors |
(Notable regional and domestic specialists further down the ranking include JJGC/Neodent of Brazil with 30 dental-implant registrations and Egypt’s own Pharmaplast S.A.E with 28 wound-care registrations.)
1. Boston Scientific’s Portfolio Strength (130 Registrations)
Boston Scientific’s position at the top of the registry reflects its extensive cardiovascular and electrophysiology catalog. 130 records list Boston Scientific Corporation as the primary manufacturer, and across every manufacturer-name variant — including records that also name its Irish (Boston Scientific Limited) and Costa Rican subsidiaries — Boston Scientific entities appear in close to 148 records in total. These registrations represent high-risk Class C and D devices, highlighting the EDA’s active approval of high-value interventional technologies that are not manufactured locally in Egypt.
2. The Success of Ameco Medical Industries (42 Registrations)
Ameco Medical Industries is a major success story for Egypt's domestic medical device industry. Headquartered in Cairo, Ameco manufactures catheters and catheter-related accessories for hemodialysis, oncology, and drainage applications. Their 42 approvals represent Class B and C devices, proving that domestic Egyptian companies can successfully design, manufacture, and register complex sterile catheters that compete directly with imports from European and American manufacturers.
3. Pharmaplast's Wound Care Footprint (28 Registrations)
Pharmaplast, founded in Kafr El-Zayat, Egypt, is a leading manufacturer of wound care products. They supply advanced foam and hydrogel dressings globally under private labels and their own brand. Their 28 registrations represent Class A and B devices, demonstrating a strong domestic capability in medical textiles and sterile dressings.
Country of Origin Distribution
Analyzing the country-of-origin data in the public EDA register reveals the primary sourcing channels for medical devices in Egypt. However, a significant data quality issue must be noted: 79.5% of the records (3,147 out of 3,959) in the public database do not have their country-of-origin fields populated.
Among the 812 registrations where the country of origin is explicitly filled, the distribution is as follows:
graph TD
A[Populated Origin Records: 812] --> B[United States: 125 - 15.39%]
A --> C[Egypt: 103 - 12.68%]
A --> D[China: 93 - 11.45%]
A --> E[Italy: 56 - 6.90%]
A --> F[Other Countries: 435 - 53.58%]
(Note: The above diagram illustrates the country-of-origin distribution for the subset of records with populated fields.)
Key Sourcing Channels
- The United States (125 registrations): Represents the leading exporter in the registry, primarily for high-risk, technically advanced medical systems.
- Egypt (103 registrations): Highlights the growing domestic segment, consisting mainly of single-use disposables, wound care, and basic clinical consumables.
- China (93 registrations): Chinese companies are expanding rapidly in Egypt. They have focused on registering Class B consumables, imaging monitors, and dental components, offering cost-competitive alternatives to Western products for Egypt's public hospital networks.
- Italy (56 registrations): Represents a strong European connection, particularly in clinical laboratory equipment, diagnostic reagents, and orthopedic implants.
Germany (51 registrations), India (40), France (31), and Sweden (31) round out the next tier, confirming that Egypt's imported device supply is drawn from a broad base of established Western and Asian manufacturing geographies rather than a single dominant source.
Registration Timelines and Digital Growth Trends
The year-by-year approval statistics in the EDA registry show a clear acceleration in registration volume following the implementation of the MeDevice portal.
| Approval Year | Number of Approved Registrations | Cumulative Registrations | Milestone & Context |
|---|---|---|---|
| 2016 | 61 | 61 | Early pre-mandatory entries |
| 2017 | 84 | 145 | Pre-mandatory registrations |
| 2018 | 106 | 251 | Mandatory device registration begins (Sep 2018) |
| 2019 | 125 | 376 | EDA established under Law 151 of 2019 |
| 2020 | 221 | 597 | Pandemic period; early digitization |
| 2021 | 220 | 817 | MeDevice portal launched (Jul 2021) |
| 2022 | 416 | 1,233 | Digital submissions scale up |
| 2023 | 442 | 1,675 | Fast-track pathways for reference-country devices |
| 2024 | 723 | 2,398 | Backlog clearance and automation of low-risk listings |
| 2025 | 1,007 | 3,405 | Peak Year: Full digitization and strict enforcement |
| 2026 (partial, through mid-June) | 554 | 3,959 | On-track to exceed 2025 volumes |
(Note: Years are parsed from each record's issuance date. The 2018–2020 milestone labels are approximate context; the counts themselves come directly from the public EDA register extract.)
Analyzing the 2025 Peak
The approval of 1,007 registrations in 2025 represents a major milestone. This growth was driven by:
- Transition Deadlines: The grace periods for legacy CAPA registrations ended, requiring companies to submit updated technical files through MeDevice to avoid import suspensions.
- MeDevice Stability: The digitization of reviewer workflows allowed committees to process dossiers more quickly.
- Fast-Track Approvals: The EDA expanded reliance pathways, allowing devices with valid CE certificates (under EU MDR) or US FDA 510(k)/PMA clearances to bypass redundant technical evaluations and obtain approval in a condensed timeframe.
The momentum has continued into 2026, with 554 registrations already recorded by mid-year — a pace that, if sustained, would push annual volume above the 2025 peak and further entrench the EDA's electronic submission system as the default route to the Egyptian market.
Step-by-Step Pathway for Registering Devices via MeDevice
To successfully navigate the EDA registration process, foreign manufacturers must understand the practical workflow required for a MeDevice submission:
[Appoint Egyptian Registration Holder (ERH)]
│
▼
[Compile Technical Dossier (ISO 13485, CE, CFS)]
│
▼
[Submit Application via MeDevice Portal]
│
▼
┌─────────────────┴─────────────────┐
▼ ▼
[EDA Administrative Review] [EDA Technical Committee Review]
│ │
└─────────────────┬─────────────────┘
▼
[Review Deficiency Letters]
│
▼
[Obtain EDA Registration License]
1. Appoint an Egyptian Registration Holder (ERH)
A foreign manufacturer must appoint a local legal entity in Egypt to act as their ERH. The ERH must be licensed by the EDA as a Scientific Office or a medical device distributor. The ERH holds the registration certificate in the database on behalf of the manufacturer.
2. Compile the Technical Dossier
The required documentation is structured around the Common Submission Dossier Template (CSDT) and must include:
- ISO 13485:2016 Certificate: Must be issued by a certification body recognized by the EDA (typically accredited by an IAF member).
- Certificate of Free Sale (CFS): Issued by the competent authority in the country of origin, stating that the device is legally marketed there.
- CE Mark / FDA Clearance: High-risk devices (Class B, C, D) generally require a valid CE certificate or US FDA clearance. High-risk devices without reference country approvals face an extensive, lengthy technical committee review.
- Device Labels and IFU: User instructions must be in English for professional devices, and must include Arabic translations for any devices designed for home or domestic use.
3. Submission and Deficiency Resolution
The ERH uploads all documents to the MeDevice portal. The EDA administrative team checks the completeness of the file, after which the technical committee reviews the clinical evidence and safety data. If the committee issues a deficiency letter (خطاب نواقص), the applicant has a strict window (typically 60 working days) to upload the requested documents. Failure to respond within this window results in the application being rejected, requiring a new submission and repayment of fees.
Strategic Insights for Medtech Exporters
Based on the quantitative trends in the EDA registry, medical device exporters should adopt the following strategic practices:
1. Separate License Ownership from Commercial Distribution
Because EDA registrations are valid for 10 years, they are highly valuable regulatory assets. If you appoint a commercial distributor as your ERH, you risk channel lock-in. If you need to terminate the distribution agreement due to underperformance, transferring the registration certificate to a new distributor requires the active sign-off of the original ERH. If the distributor refuses, your product will be blocked from entering Egypt for a significant period.
Consider appointing an independent Scientific Office in Cairo to act as your ERH. The Scientific Office holds the regulatory license, allowing you to contract with multiple commercial distributors or change dealers without regulatory disruption. This strategy is also discussed in our regional MENA digital health regulation guide.
2. Capitalize on the CE Exemption Pathways
To accelerate your time-to-market, leverage your existing European CE marks or US FDA clearances. The EDA's fast-track pathway for reference-country approvals reduces the review timeline from 12-18 months to 3-6 months. Ensure that your CFS matches the exact manufacturing facility and product codes listed on your ISO 13485 and CE certificates.
3. Plan for Public Procurement (UPA Tenders)
The Egyptian Authority for Unified Procurement, Medical Supply, and Technology Management — commonly abbreviated UPA (Unified Procurement Authority), and established under the same Law No. 151 of 2019 as the EDA — holds exclusive responsibility for procuring medical products on behalf of Egypt's public health entities (the Ministry of Health, the Health Insurance Organization, and others). To bid on UPA tenders, a device must be active in the EDA database. Ensure that your ERH initiates the registration process well in advance of UPA bidding cycles, as registration cannot be bypassed for public purchases.
Reference-Country Fast-Track: How Prior Approvals Shorten the Path
Egypt's registry growth has been accelerated by the EDA's reliance on reference-country approvals. Devices that already hold a CE mark (EU MDR) or US FDA 510(k)/PMA clearance can bypass much of the duplicated technical evaluation. The table summarizes how the strength of your existing approvals shapes the EDA review path.
| Prior Approval You Hold | EDA Treatment | Typical Review Impact |
|---|---|---|
| Valid CE certificate (EU MDR) | Recognized reference-country approval | Condensed technical review; fast-track eligibility |
| US FDA 510(k) or PMA clearance | Recognized reference-country approval | Condensed technical review; fast-track eligibility |
| No reference-country approval | Full technical committee evaluation | Longer, more detailed dossier scrutiny |
| Certificate of Free Sale (CFS) only | Supports lawful marketing claim; not a substitute for technical review | Required supporting document, not a shortcut |
The dominance of US multinationals in the populated country-of-origin field (125 US-origin records, ahead of Egypt at 103 and China at 93) is consistent with this pattern: companies that already hold FDA or CE approvals can move through the EDA process more quickly and cheaply, so they tend to register more products. Manufacturers whose only market history is in non-reference jurisdictions should budget for a longer review and a fuller clinical and technical file.
What Device Categories Dominate the Egyptian Register?
Looking beyond manufacturer names, the populated product-category field shows where Egypt's clinical demand and regulatory throughput are concentrated. The most frequently registered specific product types point to three demand clusters:
- Interventional cardiology and radiology — PTCA and PTA balloon dilatation catheters, coronary guide wires, and pacemakers each appear dozens of times, reflecting both the burden of cardiovascular disease and the prevalence of US and European high-risk device approvals.
- Dental implants and prosthetics — dental implant systems and abutments are among the most common specific categories, consistent with the strong showing of Brazilian (JJGC/Neodent) and European dental manufacturers.
- Aesthetics and regenerative products — dermal filler pre-filled syringes and assisted-reproduction media are heavily represented categories, indicating a sizable private-market aesthetic and fertility segment that registers actively with the EDA.
A large residual block of records carries the generic category label "Others," which limits category-level precision, but the named categories above confirm an Egyptian register tilted toward cardiovascular intervention, dental reconstruction, and private aesthetic medicine rather than low-cost disposables.
Frequently Asked Questions (FAQ)
How many medical devices are registered in the Egypt EDA database?
As of June 2026, the public electronic registry of the Egyptian Drug Authority contains 3,959 approved medical device registrations.
Which manufacturer has the most registrations in Egypt's EDA database?
Boston Scientific Corporation leads all registered manufacturers with 130 registrations listing it as the primary manufacturer (close to 148 across all Boston Scientific entities), followed by Egypt's domestic Ameco Medical Industries with 42 approvals.
How long is an EDA medical device registration license valid?
Under the current regulatory framework, an EDA medical device registration certificate is valid for 10 years from the date of issuance, subject to compliance with post-market surveillance and annual fee requirements.
Can a foreign manufacturer submit registration files directly to the EDA?
No. Foreign manufacturers must appoint a locally registered entity in Egypt—such as a licensed Scientific Office or distributor—to act as their Egyptian Registration Holder (ERH) and submit files via the MeDevice portal.
Are IVDs included in this EDA register analysis?
The EDA's public MedicalDevices e-service list analyzed here covers registered medical devices. Egyptian IVDs follow a related but distinct registration track, and IVD registrations carry a shorter validity period (5 years) than medical devices (10 years). Treat the 3,959-record total as a medical-device-centric view of the market rather than a combined device-plus-IVD count.
How reliable is the country-of-origin data in the public EDA register?
It is sparse. Only about 20.5% of the 3,959 records (812 entries) have a populated country-of-origin field, so the country ranking (United States, Egypt, China, Italy) describes that filled subset rather than the whole register. The blank-field rate is a data-quality limitation of the public e-service view itself, not an analytical choice; readers should treat the country shares as directional rather than exhaustive.
What is an Egyptian Registration Holder (ERH) and why does the choice matter?
The ERH is the locally registered Egyptian entity — typically a licensed Scientific Office or medical device distributor — that submits and legally holds your EDA registration on your behalf. Because EDA registrations are valid for 10 years, the ERH controls a long-lived regulatory asset: transferring a registration to a new holder generally requires the original ERH's cooperation. Appointing a commercial distributor as ERH therefore creates channel lock-in, while using an independent Scientific Office lets you keep regulatory ownership separate from sales and switch commercial partners without re-registering. The registry data showing strong US and domestic manufacturer presence reflects, in part, which ERH models have proven able to shepherd large portfolios through the MeDevice process.
Conclusion & Legal Disclaimer
Analyzing the Egyptian Drug Authority's registration database highlights the modernization and growth of Egypt's medical device market. The growth in approvals, peaking in 2025, reflects the success of the MeDevice portal in digitalizing submissions. For international manufacturers, selecting the right Egyptian Registration Holder and leveraging reference-country pathways are critical steps to achieving long-term market access in Egypt. With registrations already running ahead of the 2025 pace in the first half of 2026, the EDA register is likely to keep expanding quickly, rewarding manufacturers that move early, hold recognized CE or FDA approvals, and structure their ERH relationship to preserve flexibility as the market matures.
Disclaimer: This analysis is based on public registration data from the Egyptian Drug Authority (EDA) registry as of June 2026. The information provided in this article is for educational and market intelligence purposes only and does not constitute legal, regulatory, or quality-system advice for any specific product or organization. For specific regulatory filings, consult with a qualified regulatory affairs professional or your local representative in Egypt.
Sources
- Egyptian Drug Authority Public E-Service Register: Egyptian Drug Authority (EDA) Official Portal.
- MeDevice Electronic Registration Portal: Egyptian Drug Authority (EDA).
- Law No. 151 of 2019 establishing the Egyptian Drug Authority: Egyptian Government Gazette.
- EDA Medical Device Control Division Announcements and Decrees: EDA Official Portal.
- International Trade Administration (ITA) Egypt Country Commercial Guide: U.S. Department of Commerce.